An IRB member's perspective on access to innovative therapy.
D020811:Biomedical Technology; D002648:Child; D030881:Disclosure; D015507:Drugs, Investigational; D026724:Ethical Review; D004989:Ethics; D017041:Ethics Committees; D028744:Ethics Committees, Research; D035082:Federal Government; D005333:Fetus; D006076:Government; D033161:Government Regulation; D006761:Hospitals; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D007326:Institutionalization; D016743:Mental Competency; D033281:Nontherapeutic Human Experimentation; D009934:Organization and Administration; D018579:Patient Selection; D009272:Persons; D019989:Persons with Intellectual Disabilities; D011329:Prisoners; D012106:Research; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D012959:Socioeconomic Factors; D036302:Therapeutic Human Experimentation; D035703:Therapies, Investigational; D020458:Third-Party Consent; D014481:United States; D035862:Vulnerable Populations
Biomedical and Behavioral Research